Key result
A C-terminal fragment (residues 369 to 435) of Vitamin D-binding protein binds to monomeric actin with lower affinity than full-length DBP and inhibits actin denaturation and polymerisation.
The C-terminal fragment of Vitamin D-binding protein binds to actin and modulates its polymerization, suggesting distinct sites on actin for nucleation and elongation.
No immediate clinical implications; leaves open DBP fragment roles in actin regulation for future preclinical validation.
The vitamin D-binding protein (DBP) binds to monomeric actin with high affinity. The variation in DBP isoforms is due to genetic polymorphism and varying glycosylation. To obtain a homogeneous preparation, the cDNA for human DBP and truncations thereof were cloned and various systems were applied for heterologous bacterial and yeast expression. The full-length protein and the N- and C-terminal halves of DBP remained insoluble probably because the protein did not fold to its native three-dimensional structure due to formation of accidental intra- and inter-molecular disulfide bonds during expression in bacteria or yeast. This problem was overcome by cloning of a C-terminal fragment comprising residues 369 to 435 that did not contain disulfide bonds and was completely soluble. Binding of the C-terminal fragment to monomeric actin was demonstrated by comigration with actin during native polyacrylamide gel electrophoresis and surface plasmon resonance, however, at considerably lower affinity than full-length DBP. This suggests that in addition to the C-terminal amino acid sequence other parts (amino acid residues or sugar moieties) of DBP participate in actin binding. The C-terminal fragment was found to inhibit denaturation of actin and to decrease the rate of actin polymerisation both at the barbed and at the pointed end in a concentration-dependent manner. According to a quantitative analysis of the polymerisation kinetics, association of actin monomers to nucleate filaments was not prevented by binding of the C-terminal fragment to actin. These data suggest that the sites on the surface of actin that are involved in actin nucleation and elongation are different.
No takes yet. Share an insight, caveat, or question.
Buch et al. (2002) studied this question. C-terminal fragment (residues 369 to 435) of Vitamin D-binding protein vs. Full-length DBP was evaluated on Binding to monomeric actin and effect on actin polymerisation. A C-terminal fragment (residues 369 to 435) of Vitamin D-binding protein binds to monomeric actin with lower affinity than full-length DBP and inhibits actin denaturation and polymerisation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: